 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
17 April 2001 | Volume 134 Issue 8 | Pages 663-694
Overwhelming evidence now indicates that the quality of reporting of randomized, controlled trials (RCTs) is less than optimal. Recent methodologic analyses indicate that inadequate reporting and design are associated with biased estimates of treatment effects. Such systematic error is seriously damaging to RCTs, which boast the elimination of systematic error as their primary hallmark. Systematic error in RCTs reflects poor science, and poor science threatens proper ethical standards.
A group of scientists and editors developed the CONSORT (Consolidated Standards of Reporting Trials) statement to improve the quality of reporting of RCTs. The statement consists of a checklist and flow diagram that authors can use for reporting an RCT. Many leading medical journals and major international editorial groups have adopted the CONSORT statement. The CONSORT statement facilitates critical appraisal and interpretation of RCTs by providing guidance to authors about how to improve the reporting of their trials.
This explanatory and elaboration document is intended to enhance the use, understanding, and dissemination of the CONSORT statement. The meaning and rationale for each checklist item are presented. For most items, at least one published example of good reporting and, where possible, references to relevant empirical studies are provided. Several examples of flow diagrams are included.
The CONSORT statement, this explanatory and elaboration document, and the associated Web site (http://www.consort-statement.org) should be helpful resources to improve reporting of randomized trials.
Throughout the text, terms marked with an asterisk are defined at end of text.
Author and Article Information
From ICRF Medical Statistics Group and Centre for Statistics in Medicine, Institute of Health Sciences, Oxford, MRC Health Services Research Collaboration, University of Bristol, Bristol, and London School of Hygiene and Tropical Medicine, London, United Kingdom; Family Health International and The School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Thomas C. Chalmers Centre for Systematic Reviews, Ottawa, Ontario, Canada; American College of Physicians–American Society of Internal Medicine, Philadelphia, Pennsylvania; Nordic Cochrane Centre, Copenhagen, Denmark; and Tom Lang Communications, Lakewood, Ohio.
Acknowledgments: The authors thank Leah Lepage for coordinating the activities of the CONSORT group and Margaret J. Sampson, Louise Roy, and Kaitryn Campbell for creating a database of references.
Grant Support: Financial support to convene meetings of the CONSORT group was provided in part by Abbott Laboratories, American College of Physicians–American Society of Internal Medicine, GlaxoWellcome, The Lancet, Merck, the Canadian Institutes for Health Research, National Library of Medicine, and TAP Pharmaceuticals.
Requests for Single Reprints: Leah Lepage, PhD, Thomas C. Chalmers Centre for Systematic Reviews, Children's Hospital of Eastern Ontario Research Institute, Room R235, 401 Smyth Road, Ottawa, Ontario K1H 8L1, Canada; e-mail, llepage{at}uottawa.ca.
Current Author Addresses: Professor Altman: ICRF Medical Statistics Group, Centre for Statistics in Medicine, Institute of Health Sciences, Old Road, Headington, Oxford OX3 7LF, United Kingdom.
Dr. Schulz: Quantitative Sciences, Family Health International, PO Box 13950, Research Triangle Park, NC 27709.
Mr. Moher: Thomas C. Chalmers Center for Systematic Reviews, Children's Hospital of Eastern Ontario Research Institute, Room R2226, 401 Smyth Road, Ottawa, Ontario K1H 8L1, Canada.
Dr. Egger: MRC Health Services Research Collaboration, University of Bristol, Canynge Hall, Whiteladies Road, Bristol B58 2PR, United Kingdom.
Dr. Davidoff: Annals of Internal Medicine, American College of Physicians–American Society of Internal Medicine, 190 N. Independence Mall West, Philadelphia, PA 19106.
Professor Elbourne: Medical Statistics Unit, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, United Kingdom.
Dr. Gøtzsche: Nordic Cochrane Centre, Rigshospitalet, Dept 7112, Blegdamsvej 9, DK-2100 Copenhagen Ø, Denmark.
Mr. Lang: 13849 Edgewater Drive, Lakewood, OH 44107. ACADEMIA AND CLINIC
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  S. Zohar, Qing Lian, V. Levy, K. Cheung, A. Ivanova, and S. Chevret Quality assessment of phase I dose-finding cancer trials: proposal of a checklist Clinical Trials, October 1, 2008; 5(5): 478 - 485. [Abstract] [PDF]
|
|
|
|
 |
|
 T. R Fenton, M. Eliasziw, A. W Lyon, S. C Tough, and D. A Hanley Meta-analysis of the quantity of calcium excretion associated with the net acid excretion of the modern diet under the acid-ash diet hypothesis Am. J. Clinical Nutrition, October 1, 2008; 88(4): 1159 - 1166. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. von Elm and D. G. Altman Reporting Guidelines: Looking Back From the Future Chest, October 1, 2008; 134(4): 682 - 684. [Full Text] [PDF]
|
|
|
|
 |
|
 F Davidoff, P Batalden, D Stevens, G Ogrinc, S Mooney, and for the SQUIRE development group Publication guidelines for quality improvement in health care: evolution of the SQUIRE project Qual. Saf. Health Care, October 1, 2008; 17(Suppl_1): i3 - i9. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. P. Rios, A. Odueyungbo, M. O. Moitri, M. O. Rahman, and L. Thabane Quality of Reporting of Randomized Controlled Trials in General Endocrinology Literature J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3810 - 3816. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Zhu, Y. Liu, L. Wang, and Q. H. Meng Transforming growth factor-{beta}1 is associated with kidney damage in patients with essential hypertension: renoprotective effect of ACE inhibitor and/or angiotensin II receptor blocker Nephrol. Dial. Transplant., September 1, 2008; 23(9): 2841 - 2846. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Shcherbatykh, A. Holbrook, L. Thabane, L. Dolovich, and COMPETE III investigators Methodologic Issues in Health Informatics Trials: The Complexities of Complex Interventions J. Am. Med. Inform. Assoc., September 1, 2008; 15(5): 575 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Y. Yuen and J. E. Pope Learning from past mistakes: assessing trial quality, power and eligibility in non-renal systemic lupus erythematosus randomized controlled trials Rheumatology, September 1, 2008; 47(9): 1367 - 1372. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Camporese, E. Bernardi, P. Prandoni, F. Noventa, F. Verlato, P. Simioni, K. Ntita, G. Salmistraro, C. Frangos, F. Rossi, et al. Low-Molecular-Weight Heparin versus Compression Stockings for Thromboprophylaxis after Knee Arthroscopy: A Randomized Trial Ann Intern Med, July 15, 2008; 149(2): 73 - 82. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Breivik, P. C. Borchgrevink, S. M. Allen, L. A. Rosseland, L. Romundstad, E. K. Breivik Hals, G. Kvarstein, and A. Stubhaug Assessment of pain Br. J. Anaesth., July 1, 2008; 101(1): 17 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. T. Crowley, G. M. Chertow, J. Vitale, T. O'Connor, J. Zhang, R. M.H. Schein, D. Choudhury, K. Finkel, A. Vijayan, E. Paganini, et al. Lessons for Successful Study Enrollment from the Veterans Affairs/National Institutes of Health Acute Renal Failure Trial Network Study Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 955 - 961. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. W Berger, J R. Matthews, and E. N Grosch On improving research methodology in clinical trials Statistical Methods in Medical Research, June 1, 2008; 17(3): 231 - 242. [Abstract] [PDF]
|
|
|
|
 |
|
 S. J Pocock, T. G Travison, and L. M Wruck How to interpret figures in reports of clinical trials BMJ, May 24, 2008; 336(7654): 1166 - 1169. [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Karanicolas, M. Bhandari, B. Taromi, E. A. Akl, D. Bassler, P. Alonso-Coello, D. Rigau, D. Bryant, S. E. Smith, S. D. Walter, et al. Blinding of Outcomes in Trials of Orthopaedic Trauma: An Opportunity to Enhance the Validity of Clinical Trials J. Bone Joint Surg. Am., May 1, 2008; 90(5): 1026 - 1033. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Wykes, C. Steel, B. Everitt, and N. Tarrier Cognitive Behavior Therapy for Schizophrenia: Effect Sizes, Clinical Models, and Methodological Rigor Schizophr Bull, May 1, 2008; 34(3): 523 - 537. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. F. Clark and J. M. Sontrop What Have We Learned about Optimal Induction Therapy for Lupus Nephritis (III through V) from Randomized, Controlled Trials? Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 895 - 898. [Full Text] [PDF]
|
|
|
|
|
|
S. Eldridge, D. Ashby, C. Bennett, M. Wakelin, and G. Feder Internal and external validity of cluster randomised trials: systematic review of recent trials BMJ, April 19, 2008; 336(7649): 876 - 880. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Pavone, U. Ricardi, S. Luminari, P. Gobbi, M. Federico, L. Baldini, E. Iannitto, G. Ucci, L. Marcheselli, L. Orsucci, et al. ABVD plus radiotherapy versus EVE plus radiotherapy in unfavorable stage IA and IIA Hodgkin's lymphoma: results from an Intergruppo Italiano Linfomi randomized study Ann. Onc., April 1, 2008; 19(4): 763 - 768. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Shirazi, A. Zeinaloo, S. Parikh, M Sadeghi, A Taghva, M Arbabi, A S. Kashani, F Alaeddini, K Lonka, and R Wahlstrom Effects on readiness to change of an educational intervention on depressive disorders for general physicians in primary care based on a modified Prochaska model--a randomized controlled study Fam. Pract., April 1, 2008; 25(2): 98 - 104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. I. Kottink, H. J Hermens, A. V Nene, M. J Tenniglo, C. G Groothuis-Oudshoorn, and M. J IJzerman Therapeutic Effect of an Implantable Peroneal Nerve Stimulator in Subjects With Chronic Stroke and Footdrop: A Randomized Controlled Trial Physical Therapy, April 1, 2008; 88(4): 437 - 448. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Djulbegovic, A. Kumar, H. P. Soares, I. Hozo, G. Bepler, M. Clarke, and C. L. Bennett Treatment Success in Cancer: New Cancer Treatment Successes Identified in Phase 3 Randomized Controlled Trials Conducted by the National Cancer Institute-Sponsored Cooperative Oncology Groups, 1955 to 2006 Arch Intern Med, March 24, 2008; 168(6): 632 - 642. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Wood, M. Egger, L. L. Gluud, K. F Schulz, P. Juni, D. G Altman, C. Gluud, R. M Martin, A. J G Wood, and J. A C Sterne Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study BMJ, March 15, 2008; 336(7644): 601 - 605. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cleary, G. E. Hunt, S. Matheson, N. Siegfried, and G. Walter Psychosocial Treatment Programs for People With Both Severe Mental Illness and Substance Misuse Schizophr Bull, March 1, 2008; 34(2): 226 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Hughes, L. Stewart, J. Chapple, J. H. McColl, M. D. C. Donaldson, C. J. H. Kelnar, M. Zabihollah, F. Ahmed, and J. J. Reilly Randomized, Controlled Trial of a Best-Practice Individualized Behavioral Program for Treatment of Childhood Overweight: Scottish Childhood Overweight Treatment Trial (SCOTT) Pediatrics, March 1, 2008; 121(3): e539 - e546. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Boutron, D. Moher, D. G. Altman, K. F. Schulz, P. Ravaud, and for the CONSORT Group Extending the CONSORT Statement to Randomized Trials of Nonpharmacologic Treatment: Explanation and Elaboration Ann Intern Med, February 19, 2008; 148(4): 295 - 309. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Boutron, D. Moher, D. G. Altman, K. F. Schulz, P. Ravaud, and for the CONSORT Group Methods and Processes of the CONSORT Group: Example of an Extension for Trials Assessing Nonpharmacologic Treatments Ann Intern Med, February 19, 2008; 148(4): W-60 - W-66. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Marmor, I. Belitskaya-Levy, and A. A. Arslan RE: LETTER TO THE EDITOR ON "BIAS IN CLINICAL INTERVENTION RESEARCH" Am. J. Epidemiol., February 15, 2008; 167(4): 500 - 501. [Full Text] [PDF]
|
|
|
|
|
|
V. Hertzberg, M. Chimowitz, M. Lynn, C. Chester, W. Asbury, and G. Cotsonis Use of dose modification schedules is effective for blinding trials of warfarin: evidence from the WASID study Clinical Trials, February 1, 2008; 5(1): 23 - 30. [Abstract] [PDF]
|
|
|
|
 |
|
 C. Y. Ko, J. Parikh, and D. Zingmond Secondary Analyses of Large Population-Based Data Sets: Issues of Quality, Standards, and Understanding Ann. Surg. Oncol., February 1, 2008; 15(2): 395 - 396. [Full Text] [PDF]
|
|
|
|
|
|
S. A. Olivo, L. G. Macedo, I. C. Gadotti, J. Fuentes, T. Stanton, and D. J Magee Scales to Assess the Quality of Randomized Controlled Trials: A Systematic Review Physical Therapy, February 1, 2008; 88(2): 156 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. P. Belani, S. Ramalingam, M. C. Perry, R. V. LaRocca, D. Rinaldi, P. S. Gable, and W. J. Tester Randomized, Phase III Study of Weekly Paclitaxel in Combination With Carboplatin Versus Standard Every-3-Weeks Administration of Carboplatin and Paclitaxel for Patients With Previously Untreated Advanced Non-Small-Cell Lung Cancer J. Clin. Oncol., January 20, 2008; 26(3): 468 - 473. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Whelan, T. M. Jurgens, and L. Lord Evaluating the Quality of Randomized Controlled Trials that Examine the Efficacy of Natural Health Products: A Systematic Review of Critical Appraisal Instruments Evid. Based Complement. Altern. Med., January 18, 2008; (2008) nem186v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W. Kissane Letting Go of the Hope That Psychotherapy Prolongs Cancer Survival J. Clin. Oncol., December 20, 2007; 25(36): 5689 - 5690. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Savoye and J. Dziura Efficacy of a Weight Management Program in Overweight Children Reply JAMA, October 24, 2007; 298(16): 1860 - 1861. [Full Text] [PDF]
|
|
|
|
|
|
C. J M. Lowe, K. L Barker, M. Dewey, and C. M Sackley Effectiveness of physiotherapy exercise after knee arthroplasty for osteoarthritis: systematic review and meta-analysis of randomised controlled trials BMJ, October 20, 2007; 335(7624): 812 - 812. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Vandenbroucke, E. v. Elm, D. G. Altman, P. C. Gotzsche, C. D. Mulrow, S. J. Pocock, C. Poole, J. J. Schlesselman, M. Egger, and for the STROBE initiative Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration Ann Intern Med, October 16, 2007; 147(8): W-163 - W-194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Ziegler Mistletoe Preparation Iscador: Are there Methodological Concerns with Respect to Controlled Clinical Trials? Evid. Based Complement. Altern. Med., October 4, 2007; (2007) nem121v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Egger, D. G Altman, J. P Vandenbroucke, and of the STROBE group Commentary: Strengthening the reporting of observational epidemiology the STROBE statement Int. J. Epidemiol., October 2, 2007; (2007) dym199v1. [Full Text] [PDF]
|
|
|
|
|
|
S. Ebrahim and M. Clarke STROBE: new standards for reporting observational epidemiology, a chance to improve Int. J. Epidemiol., October 1, 2007; 36(5): 946 - 948. [Full Text] [PDF]
|
|
|
|
|
|
S. Chan and M. Bhandari The Quality of Reporting of Orthopaedic Randomized Trials with Use of a Checklist for Nonpharmacological Therapies J. Bone Joint Surg. Am., September 1, 2007; 89(9): 1970 - 1978. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Gambrill Transparency as the Route to Evidence-Informed Professional Education Research on Social Work Practice, September 1, 2007; 17(5): 553 - 560. [Abstract] [PDF]
|
|
|
|
|
|
J. Gravel, L. Opatrny, and S. Shapiro The intention-to-treat approach in randomized controlled trials: Are authors saying what they do and doing what they say? Clinical Trials, August 1, 2007; 4(4): 350 - 356. [Abstract] [PDF]
|
|
|
|
|
|
J Pildal, A Hrobjartsson, K. Jorgensen, J Hilden, D. Altman, and P. Gotzsche Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials Int. J. Epidemiol., August 1, 2007; 36(4): 847 - 857. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Demark-Wahnefried, E. C. Clipp, I. M. Lipkus, D. Lobach, D. C. Snyder, R. Sloane, B. Peterson, J. M. Macri, C. L. Rock, C. M. McBride, et al. Main Outcomes of the FRESH START Trial: A Sequentially Tailored, Diet and Exercise Mailed Print Intervention Among Breast and Prostate Cancer Survivors J. Clin. Oncol., July 1, 2007; 25(19): 2709 - 2718. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Boutron, P. Ravaud, and R. Nizard The design and assessment of prospective randomised, controlled trials in orthopaedic surgery J Bone Joint Surg Br, July 1, 2007; 89-B(7): 858 - 863. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Faggion Jr. and Y.-K. Tu Evidence-Based Dentistry: A Model for Clinical Practice J Dent Educ., June 1, 2007; 71(6): 825 - 831. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Coultas Ethical Considerations in the Interpretation and Communication of Clinical Trial Results Proceedings of the ATS, May 1, 2007; 4(2): 194 - 199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Baron, I. Boutron, B. Giraudeau, and P. Ravaud Reporting of radiographic methods in randomised controlled trials assessing structural outcomes in rheumatoid arthritis Ann Rheum Dis, May 1, 2007; 66(5): 651 - 657. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kumar, H. P. Soares, L. Balducci, and B. Djulbegovic Treatment Tolerance and Efficacy in Geriatric Oncology: A Systematic Review of Phase III Randomized Trials Conducted by Five National Cancer Institute-Sponsored Cooperative Groups J. Clin. Oncol., April 1, 2007; 25(10): 1272 - 1276. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Eldridge Good practice in statistical reporting for Family Practice Fam. Pract., April 1, 2007; 24(2): 93 - 94. [Full Text] [PDF]
|
|
|
|
 |
|
 E. Mayo-Wilson Reporting Implementation in Randomized Trials: Proposed Additions to the Consolidated Standards of Reporting Trials Statement Am J Public Health, April 1, 2007; 97(4): 630 - 633. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Laine, S. N. Goodman, M. E. Griswold, and H. C. Sox Reproducible Research: Moving toward Research the Public Can Really Trust Ann Intern Med, March 20, 2007; 146(6): 450 - 453. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Lee, J. Bindman, T. Ford, N. Glozier, P. Moran, R. Stewart, and M. Hotopf Bias in psychiatric case-control studies: Literature survey The British Journal of Psychiatry, March 1, 2007; 190(3): 204 - 209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Mandala, C Moro, G Michetti, G Ferretti, and R Labianca What is the real benefit of adjuvant chemotherapy in the Adjuvant Navelbine International Trialist Association trial? Ann. Onc., February 1, 2007; 18(2): 404 - 404. [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Cepeda, D. B. Carr, T. Sarquis, N. Miranda, R. J. Garcia, and C. Zarate Static Magnetic Therapy Does Not Decrease Pain or Opioid Requirements: A Randomized Double-Blind Trial Anesth. Analg., February 1, 2007; 104(2): 290 - 294. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Martell, P. G. O'Connor, R. D. Kerns, W. C. Becker, K. H. Morales, T. R. Kosten, and D. A. Fiellin Systematic Review: Opioid Treatment for Chronic Back Pain: Prevalence, Efficacy, and Association with Addiction Ann Intern Med, January 16, 2007; 146(2): 116 - 127. [Abstract] [Full Text] [PDF]
|
|
Article
